A Phase 2 Randomized Double-Blind Trial of Maintenance with Niraparib vs Placebo in Patients with Platinum Sensitive Ovarian Cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
TESARO
Start Date
November 1, 2013
End Date
January 31, 2021
Administered By
Duke Cancer Institute
Awarded By
TESARO
Start Date
November 1, 2013
End Date
January 31, 2021